Stephen Willard
Chief Executive Officer bij NRX PHARMACEUTICALS, INC.
Vermogen: 495 600 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jonathan Javitt | M | 67 | 7 jaar | |
John Willimann | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
Kevin Walsh | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
Patrick J. Flynn | M | 75 | 3 jaar | |
Ari Helenius | M | - |
Yale University
| 41 jaar |
Chaim Hurvitz | M | 63 | 3 jaar | |
Rick Panicucci | M | 63 | - | |
Philippe Touret | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
Richard Narido | M | 46 | 1 jaar | |
Eric Lauzat | M | - |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Global Life Technologies Corp. produces nozin® nasal sanitizer® antiseptic, which is clinically proven to reduce nasal bacteria and helps reduce the risk of infection. The private company is based in Bethesda, MD. The product is used by hospitals for infection control. The company was founded by John Willimann, Kevin Walsh, Philippe Touret. John Willimann has been the CEO since incorporation. | - |
Janet Rehnquist | F | - | 1 jaar | |
Dennis K. McBride | M | - | 9 jaar | |
Carrie M. Carretta | M | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Gérard Soula | M | 78 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | 15 jaar |
Arlen W. Gelbard | M | 66 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 8 jaar |
Robert Lilien | M | 62 | 9 jaar | |
Karl Roessner | M | 56 | 10 jaar | |
Robert V. Burton | M | - |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 4 jaar |
Steven Freiberg | M | 67 | 2 jaar | |
Michael E. Foley | M | 71 | 4 jaar | |
Christian Kalita | M | - |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Joseph Velli | M | 66 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 4 jaar |
Bryon McGregor | M | 60 | 6 jaar | |
Rodger Lawson | M | 77 | 8 jaar | |
Peter R. Knitzer | M | 65 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 1 jaar |
Rebecca Saeger | F | 69 |
E*TRADE Bank
E*TRADE Bank Regional BanksFinance E*Trade Bank provides banking services. It is the wholly-owned subsidiary of E*TRADE Financial Corp. The company is headquartered in Arlington, VA. | 8 jaar |
Matt Greenfield | M | - |
Yale University
| 16 jaar |
Robert Druskin | M | 76 | 3 jaar | |
Alessandra Daigneault | F | 61 | 1 jaar | |
Russell Elmer | M | 59 | 9 jaar | |
Craig R. Stapleton | M | 79 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Greg Framke | M | 64 | 13 jaar | |
Frank J. Petrilli | M | 73 | 1 jaar | |
Catherine Bréchignac | M | 77 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Mark Nydam | M | - |
Yale University
| 5 jaar |
Robert Besthof | M | 59 | 2 jaar | |
Jeffrey S. Haber | M | - |
Yale University
| 7 jaar |
Miguel A. Rodriguez | M | 71 |
Yale University
| 4 jaar |
Robert D. Wilder | M | - |
Yale University
| 4 jaar |
David S. Blatt | M | - |
Yale University
| 7 jaar |
Bart H. Williams | M | - |
Yale University
| 3 jaar |
Alan Rudolph | M | - |
Cellphire, Inc.
Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | 3 jaar |
Frederick Wilkinson Kanner | M | 81 | 10 jaar | |
Alexander F. Cohen | M | - |
Yale University
| 4 jaar |
Ryan Sheffield | M | - | 2 jaar | |
Herbert McMaster | M | 61 | 1 jaar | |
Robert Glaser | M | 62 |
Yale University
| 4 jaar |
Aaron Kaslow | M | 59 |
Yale University
| 7 jaar |
James Lam | M | 63 | 8 jaar | |
V. C. O. B. J. Navarre | M | 65 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Guillaume Cerutti | M | 58 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Phillandas T. Thompson | M | 50 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Todd Mackay | M | 50 | 11 jaar | |
Dan Troy | M | 64 | 1 jaar | |
Paul Idzik | M | 62 | 3 jaar | |
David I. Bokman | M | - |
Yale University
| 8 jaar |
Benoit C. van Assche | M | 78 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
John Ludwig Vogelstein | M | 89 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Donald Layton | M | 73 | 2 jaar | |
Lodewijk J. R. de Vink | M | 78 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Christopher M. Flink | M | 52 | 2 jaar | |
Jon Kayyem | M | 60 |
Yale University
| 5 jaar |
Michael Shannon Anderson | M | 75 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Seth van Voorhees | M | 63 | 1 jaar | |
Cheryl Irene Smith | M | - |
Yale University
| 7 jaar |
Joseph L. Sclafani | M | 75 | - | |
Richard J. Carbone | M | 76 | 7 jaar | |
Robert Simmons | M | 61 | 7 jaar | |
C. Cathleen Raffaeli | F | 68 | 8 jaar | |
Mitchell Caplan | M | 66 | 4 jaar | |
Ronald Fisher | M | 76 | 13 jaar | |
Lewis E. Randall | M | 82 | 30 jaar | |
Molly Cogan | F | - | - | |
John W. Campbell | M | - |
Yale University
| 3 jaar |
David Ezra Gerstenhaber | M | 63 |
Yale University
| 3 jaar |
Patrick Ennis | M | 61 |
Yale University
| 6 jaar |
Ken Griffin | M | - | 4 jaar | |
Francis J. T. Fildes | M | 79 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | - |
Bengt Robert Holmström | M | 75 |
Yale University
| 9 jaar |
Gretchen L. Temeles | M | - |
Yale University
| 3 jaar |
Ned Doubleday | M | - |
Yale University
| 4 jaar |
Joe Dannenmaier | M | - |
Yale University
| 4 jaar |
Henry E. Hooper | M | - |
Yale University
| 2 jaar |
Sujata Keshavan Guha | F | - |
Yale University
| 4 jaar |
Elise Lufkin | F | - |
Yale University
| 4 jaar |
Arie Soelendro | M | 77 |
Yale University
| - |
Herbert Allen | M | - |
Yale University
| 4 jaar |
Trace Adair Urdan | M | - |
Yale University
| 4 jaar |
William J. Schnoor | M | - |
Yale University
| 3 jaar |
Mark P. Conley | M | - |
Yale University
| 4 jaar |
Vera V. J. Weintraub | F | - |
Yale University
| 2 jaar |
Karen DaCosta Perzan | F | - |
Yale University
| 3 jaar |
Manuel G.R. Rivera | M | - |
Yale University
| 4 jaar |
Alan J. Ginsberg | M | 63 |
Yale University
| 4 jaar |
Kevin Francis Granger | M | 59 |
Yale University
| 4 jaar |
Robert Hazlett | M | - |
Yale University
| 4 jaar |
Elan Ezickson | M | 60 |
Yale University
| 4 jaar |
Jim Ayer | M | - |
Yale University
| 4 jaar |
James A. Giesel | M | - |
Yale University
| 4 jaar |
Tim Johnston | M | 63 |
Yale University
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 88 | 88.00% |
Frankrijk | 12 | 12.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Stephen Willard
- Persoonlijk netwerk